Supreme Court Justices Question Lethal Injection of Missouri Man
(Bloomberg) -- New Justice Brett Kavanaugh joined the Supreme Court's liberal wing in questioning whether states can use their standard execution methods to kill people whose unique medical issues leave them at risk of severe pain.
Hearing arguments in Washington on Tuesday's Election Day, the justices weighed the fate of Russell Bucklew, a Missouri inmate who says his rare medical condition means he would probably choke on his own blood if given a lethal injection. Bucklew suffers from cavernous hemangioma, a disease that has caused blood-filled tumors in his head, neck and throat.
“Are you saying even if the method creates gruesome and brutal pain, you can still do it because there's no alternative?” Kavanaugh asked Missouri Solicitor John Sauer. When Sauer said yes, Kavanaugh added, “Is there any limit on that?”
Kavanaugh, who directed all his questions during the hour-long session at Sauer, could cast the deciding vote in the case. In March the court voted 5-4 to halt Bucklew's execution, with Justice Anthony Kennedy joining the court's liberal wing in the majority. Kennedy has since retired and been replaced by Kavanaugh, President Donald Trump's second Supreme Court appointee.
The Supreme Court broadly upheld lethal injection a decade ago but left open the possibility that individual inmates could press challenges based on their particular circumstances. Bucklew, 50, has proposed that the state look to lethal gas as an alternative way of killing him.
Bucklew was convicted of bursting into the home where his ex-girlfriend, Stephanie Ray, was staying in 1996. Bucklew shot and killed the homeowner, Michael Sanders, before abducting Ray and raping her. He isn't challenging his conviction or death sentence.
Lethal Gas
Although Missouri has authorized gas as an alternative execution method, it hasn't used it since 1965 and doesn't have a functioning gas chamber. Missouri says that Bucklew must show lethal gas would be safer and that he hasn't done so.
That stance drew support from Chief Justice John Roberts. “How can it be a reasonable alternative if it's never been used before?” he asked Bucklew's lawyer, Robert Hochman.
But Justice Sonia Sotomayor wondered how the state could disclaim an execution method it had specifically authorized.
“If the statute permits it, why shouldn't they be able to choose it?” she asked.
Missouri also contends that Bucklew hasn't shown he would suffer severe pain. Justice Stephen Breyer said there were important factual questions that hadn't yet been resolved on that issue. Breyer suggested the two sides “go back and hold a full hearing” on Bucklew's situation.
Sotomayor noted that Bucklew recently underwent a tracheotomy, and she asked whether the tube was still in place. Hochman said yes but added that officials could decide to remove it.
“If the trach stays, it's a totally different case than if it's removed,” Sotomayor said.
The case, which the court will decide by June, is Bucklew v. Precythe, 17-8151.
To contact the reporter on this story: Greg Stohr in Washington at gstohr@bloomberg.net
To contact the editors responsible for this story: Joe Sobczyk at jsobczyk@bloomberg.net, Laurie Asséo, Elizabeth Wasserman
©2018 Bloomberg L.P.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.